Synergistic herbal compositions comprising combination of extracts, fractions or phytochemicals or mixtures thereof derived from Moringa oleifera, Murraya koenigii and Curcuma longa for increasing lean body mass and brown adipose tissue; for accelerating the conversion of the white adipose tissue (WAT) to brown adipose tissue (BAT), inhibiting excessive generation of advanced glycation end (AGE) products and disease conditions associated with increased levels of advanced glycation end (AGE) products. The invention further provides a method of increasing lean body mass and brown adipose tissue; accelerating the conversion of the white adipose tissue (WAT) to brown adipose tissue (BAT), inhibiting excessive generation of advanced glycation end (AGE) products and disease conditions associated with increased levels of advanced glycation end (AGE) products in mammals.

Methods of producing a Hydrophilic Homeopathic Aqueous Substance Active (HASA)-gel matrix, include the steps of: (a) combining a homeopathic compound and an uninhibited aqueous composition to produce a HASA; (b) combining the HASA with at least one hydrophilic gelling agent; and (c) thereafter, forming the hydrophilic HASA-gel matrix by use of at least one of a thickening agent, a crosslinking agent, or a polymerization agent.

Methods of producing a Hydrophilic Homeopathic Aqueous Substance Active (HASA)-gel matrix, include the steps of: (a) combining a homeopathic compound and an uninhibited aqueous composition to produce a HASA; (b) combining the HASA with at least one hydrophilic gelling agent; and (c) thereafter, forming the hydrophilic HASA-gel matrix by use of at least one of a thickening agent, a crosslinking agent, or a polymerization agent.

Methods of producing a Hydrophilic Homeopathic Aqueous Substance Active (HASA)-gel matrix, include the steps of: (a) combining a homeopathic compound and an uninhibited aqueous composition to produce a HASA; (b) combining the HASA with at least one hydrophilic gelling agent; and (c) thereafter, forming the hydrophilic HASA-gel matrix by use of at least one of a thickening agent, a crosslinking agent, or a polymerization agent.

Disclosed herein are novel thrombolytic formula for safe and effective treatment of blood clots. In clinical trials, cats of various breeds and ages presented partial or full paralysis of one or more limbs, due to arterial thromboembolism (ATE). Average treatment ranged from 3 days to 2 weeks, depending on the clot size and time elapsed since clot was dislodged from the subject's heart. These are significant findings considering the lack of treatment options available in veterinary medicine for cats with HCM and ATE. Veterinarians often euthanize cats presenting ATE, as no safe and effective thrombolytic agent is currently available for veterinary use. Previous thrombolytics were shown to have an average mortality rate of 60% due to reperfusion injury and hemorrhaging. The disclosed formula, on the other hand, overcomes these shortcomings.

The present synergistic herbal compositions comprising herbal ingredients extracted from at least two herbal species selected from the group consisting of Ocimum basilicum, Agathosma betulina, Cinnamomum cassia, Cinnamomum verum and Apium graveolens helps maintain the electrolyte and fluid balance by exerting its inhibitory secretory activity and by increasing the absorptive capacity of the intestine to prevent dehydration during an episode of infectious and non-infectious diarrhoea and in dehydration associated with various clinical and non-clinical conditions

The present synergistic herbal compositions comprising herbal ingredients extracted from at least two herbal species selected from the group consisting of Ocimum basilicum, Agathosma betulina, Cinnamomum cassia, Cinnamomum verum and Apium graveolens helps maintain the electrolyte and fluid balance by exerting its inhibitory secretory activity and by increasing the absorptive capacity of the intestine to prevent dehydration during an episode of infectious and non-infectious diarrhoea and in dehydration associated with various clinical and non-clinical conditions

The present synergistic herbal compositions comprising herbal ingredients extracted from at least two herbal species selected from the group consisting of Ocimum basilicum, Agathosma betulina, Cinnamomum cassia, Cinnamomum verum and Apium graveolens helps maintain the electrolyte and fluid balance by exerting its inhibitory secretory activity and by increasing the absorptive capacity of the intestine to prevent dehydration during an episode of infectious and non-infectious diarrhoea and in dehydration associated with various clinical and non-clinical conditions

The present invention discloses a method of preparing a bactericidal, fungicidal and anti-allergenic Zanthoxylum schinifolium skin care soap, wherein the bactericidal, fungicidal and anti-allergenic Zanthoxylum schinifolium skin care soap comprises the following components based on percentage by weight: Component A: Zanthoxylum schinifolium seed oil 15.0-21.0%, propylene glycol 12.0-17.0%, glycerin 6.0-11.0%, Component B: deionized water 5.0-8.0%, sodium alkyl ether sulfate AES 8.0-12.0%, Component C: lauric acid 5.0-8.0%, stearic acid 11.0-16.0%, Component D: 98% NaOH 2.5-4.5%, deionized water balance, Component E: Zanthoxylum schinifolium essential oil 0.3-0.8%. The skin care soap of the present invention is pale yellow and translucent, has good stability, provides great aroma and rich foam, and can nourish the skin and sterilize effectively.

A gastrointestinal health enhancing composition having an extract of Piper longum, an extract of Terminalia chebula, an extract of Murraya koenigii, an extract Zingiber officinale and an extract Glycyrrhiza glabra. Gastrointestinal health enhancing compositions having additional extracts such as secondary and/or tertiary constituents. Methods of preparing the gastrointestinal health enhancing compositions. Methods of treating gastrointestinal disorders by administering the gastrointestinal health enhancing composition.